The top stories in managed care this week included coverage of JAMA’s special issue on healthcare transformation under the ACA, changes in the proposed 2017 Physician Fee Schedule promoting value-based care, and more.
Welcome to This Week in Managed Care, from the Managed Markets News Network.
Hello, I’m Cate Douglass with The American Journal of Managed Care.
Obama Writes About the ACA in JAMA
This week, Barack Obama became the first president to publish in JAMA, which unveiled a special issue on how healthcare has changed under the Affordable Care Act. Obama said the rate of Americans without health coverage has dropped 43 percent because of the law, and fewer people report they are in fair to poor health.
The president wrote: “Americans can now count on access to health coverage throughout their lives, and the federal government has an array of tools to bring the rise of healthcare costs under control.”
The president argued that overall healthcare spending has declined, and new payment models are improving the quality of care. However, Jonathan Skinner and Amitabh Chandra, writing in the same issue, said the slowdown in spending is more likely due to the recession. Obama called on Congress to do more to rein in prescription drug process and to revisit the “public option” as a way to bring competition to parts of the country where 1 or 2 insurers dominate the market. To read more about the special issue of JAMA, visit ajmc.com.
Juno Therapeutics CAR-T Trial
Juno Therapeutics had an eventful week, after it first halted, and then resumed its trial involving leukemia patients receiving CAR-T cell treatment. The trial stopped briefly after three patients died. Juno had tried giving these patients a pretreatment combination, hoping it would make them more responsive to CAR-T treatment. The FDA gave Juno permission to restart the trial after showing it would remove one therapy from the pretreatment. The Boston Globe has reported that FDA is giving greater scrutiny to several companies develop CAR-T cell treatments
Value-Based Care in Physician’s Fee Schedule
HHS included several changes in the proposed 2017 Physician Fee Schedule that promote preventive services and value-based care. Secretary Sylvia Mathews Burwell joined the American Diabetes Association to unveil how Medicare will pay for the Diabetes Prevention Program, starting in January 2018. Those familiar with the plan say Medicare is taking its time to roll out the program, to allow time for providers to gain technical expertise to protect patient privacy, to do electronic billing, and to prevent fraud.
Studies have shown the Diabetes Prevention Program lowers the risk of a person with prediabetes progressing to the disease by 58 percent. Separately, CMS proposed paying for collaborative care, which puts behavioral health providers into primary care practices. Patients treated this way are more likely to pursue treatment for depression and to take their medication, which improves their blood glucose and cholesterol levels.
Combination Therapy and Medication Adherence
Medication adherence is a challenge in diabetes care, but Dr. John A. Johnson of WellCare recently told AJMC Insights how combination therapy can change patient perceptions and lead to better care.
For the rest of our interview with Dr. Johnson, visit ajmc.com.
Register for Patient-Centered Oncology Care
Registration is open for Patient-Centered Oncology Care, the annual multistakeholder meeting in Baltimore from AJMC. The meeting, set for November 17th and 18th will mark the fifth year of PCOC, with sessions on clinical innovations, managed care, and policy development. For information and to register, visit ajmc.com.
For all of us at the Managed Markets News Network, I’m Cate Douglass. Thanks for joining us.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More